Drug Shortage Report for TEVA-VALACYCLOVIR

Last updated on 2020-03-05 History
Report ID 97605
Drug Identification Number 02357534
Brand name TEVA-VALACYCLOVIR
Common or Proper name VALACYCLOVIR 500MG TABLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VALACYCLOVIR
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-31
Estimated end date 2020-02-29
Actual end date 2020-03-04
Shortage status Resolved
Updated date 2020-03-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-03-05 French Compare
v8 2020-03-05 English Compare
v7 2020-01-09 French Compare
v6 2020-01-09 English Compare
v5 2019-11-28 French Compare
v4 2019-11-28 English Compare
v3 2019-11-01 English Compare
v2 2019-10-31 French Compare
v1 2019-10-31 English Compare